Sale of UK’s Vaccine Manufacturing and Innovation Centre

Glover, Rebecca, Roberts, Adam ORCID: https://orcid.org/0000-0002-0760-3088, Singer, Andrew and Claas, Kirchelle (2022) 'Sale of UK’s Vaccine Manufacturing and Innovation Centre'. British Medical Journal (BMJ), Vol 376, e069999.

Preview

Text (Freely available under the BMJ Covid-19 response conditions) CK VMIC with ATs edits-REG all authors.pdf - Accepted Version Download (167kB) | Preview

Abstract

Amid a surge of infections from the omicron coronavirus variant, revelations about high profile breaches of pandemic restrictions, and deepening tensions between Ukraine and Russia, a puzzling announcement has escaped the attention of many commentators—the UK government has put its Vaccine Manufacturing and Innovation Centre (VMIC) up for sale.

Item Type:	Article
Additional Information:	Editorial
Subjects:	QW Microbiology and Immunology > Immunotherapy and Hypersensitivity > QW 805 Vaccines. Antitoxins. Toxoids WA Public Health > Preventive Medicine > WA 110 Prevention and control of communicable diseases. Transmission of infectious diseases WC Communicable Diseases > Virus Diseases > Viral Respiratory Tract Infections. Respirovirus Infections > WC 506 COVID-19
Faculty: Department:	Biological Sciences > Department of Tropical Disease Biology
Digital Object Identifer (DOI):	https://doi.org/10.1136/bmj-2022-069999
Depositing User:	Marie Hatton
Date Deposited:	28 Feb 2022 12:43
Last Modified:	28 Feb 2022 12:43
URI:	https://archive.lstmed.ac.uk/id/eprint/19991

Statistics

View details

Actions (login required)

Edit Item